FDA Approves First Nonprescription Daily Oral Contraceptive
The U.S. Food and Drug Administration (FDA) has approved Opill (norgestrel), the first daily oral contraceptive approved for use in the U.S. without a prescription. According to a new FDA news release, this approval will allow consumers to purchase an oral (tablet form) contraceptive medication without a prescription at drug stores, convenience stores, grocery stores, and online.
Wider availability of such a product could have positive implications for health equity as it may help reduce barriers to access by allowing individuals to obtain an oral contraceptive over-the-counter. This could potentially prevent millions of unintended pregnancies that are associated with various negative maternal and perinatal outcomes.